1.
|
Bianchi G, Anderson KC, Harris NL and
Sohani AR: The heavy chain diseases: Clinical and pathologic
features. Oncology (Williston Park). 28:45–53. 2014.PubMed/NCBI
|
2.
|
Fermand JP, Brouet JC, Danon F and
Seligmann M: Gamma heavy chain “disease”: Heterogeneity of the
clinicopathologic features. Report of 16 cases and review of the
literature. Medicine (Baltimore). 68:321–335. 1989. View Article : Google Scholar : PubMed/NCBI
|
3.
|
Franklin EC, Lowenstein J, Bigelow B and
Meltzer M: Heavy chain disease - a new disorder of serum
gamma-globulins: Report of the first case. Am J Med. 37:332–350.
1964. View Article : Google Scholar : PubMed/NCBI
|
4.
|
Wahner-Roedler DL, Witzig TE, Loehrer LL
and Kyle RA: Gamma-heavy chain disease: Review of 23 cases.
Medicine (Baltimore). 82:236–250. 2003. View Article : Google Scholar : PubMed/NCBI
|
5.
|
Okuda K, Himeno Y, Toyama T, Ohta M,
Kitagawa M and Sugai S: Gamma heavy chain disease and giant lymph
node hyperplasia in a patient with impaired T cell function. Jpn J
Med. 21:109–114. 1982. View Article : Google Scholar : PubMed/NCBI
|
6.
|
Zhang L, Sotomayor EM, Papenhausen PR,
Shao H, Moscinski LC, Sandin RL, Caceres G, Valenica H, Malafa M,
List AF and Sokol L: Unusual concurrence of T-cell large granular
lymphocytic leukemia with Franklin disease (gamma heavy chain
disease) manifested with massive splenomegaly. Leuk Lymphoma.
54:205–208. 2013. View Article : Google Scholar : PubMed/NCBI
|
7.
|
Bieliauskas S, Tubbs RR, Bacon CM, Eshoa
C, Foucar K, Gibson SE, Kroft SH, Sohani AR, Swerdlow SH and Cook
JR: Gamma heavy-chain disease: Defining the spectrum of associated
lymphoproliferative disorders through analysis of 13 cases. Am J
Surg Pathol. 36:534–543. 2012. View Article : Google Scholar : PubMed/NCBI
|
8.
|
Swerdlow SH, Campo E, Harris NL, Jaffe ES,
Pileri SA, Stein H, Thiele J and Vardiman JW: WHO Classification of
Tumours of Haematopoietic and Lymphoid Tissues. 2:(4th). Lyon,
France: IARC Press. 194–199. 2008.
|
9.
|
Ogawa K, Imai M, Tanigawa T, Tsuji T and
Arima T: Pathological studies on a long-term survived case of gamma
heavy chain disease - a brief review of 30 reported cases and a
proposal for histological typing. Acta Pathol Jpn. 28:759–778.
1978.PubMed/NCBI
|
10.
|
Arnason JE and Mendez LM: Induction
therapy for gamma-heavy chain disease with bortezomib and
dexamethasone: A case report. Blood. 120:50512012.
|
11.
|
Wahner-Roedler DL and Kyle RA: Heavy chain
diseases. Best Pract Res Clin Haematol. 18:729–746. 2005.
View Article : Google Scholar : PubMed/NCBI
|
12.
|
Daval S, Tridon A, Mazeron N, Ristori JM
and Evrard B: Risk of antigen excess in serum free light chain
measurements. Clin Chem. 53:1985–1986. 2007. View Article : Google Scholar : PubMed/NCBI
|
13.
|
Johannis W, Blommer J, Klatt AR, Renno JH
and Wielckens K: Gamma heavy chain disease in a patient with
rheumatoid arthritis - a laboratory evaluation. Biochem Med
(Zagreb). 22:373–379. 2012. View Article : Google Scholar : PubMed/NCBI
|
14.
|
Busser B, Millet S, Bulabois CE, Faure P
and Renversez JC: Unusual increased beta-globulins in an elderly
patient. Clin Chem. 57:948–951. 2011. View Article : Google Scholar : PubMed/NCBI
|